Bellevue Asset Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23
Closed -$1K 498
2022
Q3
$1K Buy
+23
New +$1.07K ﹤0.01% 489
2022
Q2
Sell
-23
Closed -$2K 540
2022
Q1
$2K Buy
23
+5
+28% +$360 ﹤0.01% 489
2021
Q4
$1K Sell
18
-1
-5% -$100 ﹤0.01% 560
2021
Q3
$2K Hold
19
﹤0.01% 548
2021
Q2
$3K Sell
19
-2
-10% -$312 ﹤0.01% 483
2021
Q1
$3K Sell
21
-3
-13% -$490 ﹤0.01% 542
2020
Q4
$4K Sell
24
-8
-25% -$1.3K ﹤0.01% 492
2020
Q3
$5K Sell
32
-6
-16% -$802 ﹤0.01% 412
2020
Q2
$5K Hold
38
0.01% 409
2020
Q1
$5K Buy
38
+18
+90% +$2.17K 0.01% 402
2019
Q4
$2K Buy
+20
New +$1.98K ﹤0.01% 467

Other funds holding NVRO

Bellevue Asset Management's NVRO Position: Q4 2022 in Review

Bellevue Asset Management sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 23 shares — an estimated $1K sold.

Bellevue Asset Management first reported a position in NVRO in Q4 2019 and held it in 11 quarters. The position peaked at $5K in Q3 2020. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Bellevue Asset Management reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Bellevue Asset Management sold 23 NEVRO CORP. shares in Q4 2022, an estimated $1K.
  • Bellevue Asset Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 11 quarters.
  • Bellevue Asset Management's NEVRO CORP. position peaked at $5K in Q3 2020.
  • 170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Bellevue Asset Management's 13F filing for Q4 2022, filed 23 Jan 2023.